The James Buchanan Brady Urological Institute
 
 
 
Arthur L. Burnett, II, M. D. Arthur L. Burnett, II, M. D., M.B.A.
Patrick C. Walsh Distinguished Professor of Urology
Director, Basic Science Laboratory in Neurourology
Director, Sexual Medicine Fellowship Program
Faculty Member, Cellular and Molecular Medicine Graduate Training Program

Johns Hopkins Medical Institutions

Email:aburnett@jhmi.edu

Instructions for patients

Free Access to abstracts at PubMed

RESEARCH ACTIVITIES


Publications:

Peer-reviewed scientific articles

  1. Takahashi, L.K.., Lisk, R.D., Burnett, A.L. II: “Dual Estradiol Action in Diencephalon and the Regulation of Socio-sexual Behavior in Female Golden Hamsters.” Brain Res., 359 (1985),194-207.

  2. Berrettini, W.H., Bardakjian, J., Cappelari, C.B., Burnett, A.L. Jr., Albright, A.,Nurnberger, J.1., Gershon, E. S.: “ Skin Fibroblast Beta-Adrenergic Receptor Function in Manic-Depressive Illness.” Biol. Psychiatry, 22 (1987),1439-43.

  3. Burnett, A.L., Epstein, J.I., Marshall, F.F.: “Radical Cystectomy for Transitional Cell Carcinoma of the Bladder: Long Term Survival in High Risk Patients.” Eur. Urol., 15 (1988), 171-5.

  4. Burnett, A.L., Epstein, J.I., Marshall, F.F.: “Adenocarcinoma of Urinary Bladder: Classification and Management.” Urology, 37,4 (1991),315-21.

  5. Burnett, A.L., Lowenstein, C.J., Bredt, D.S., Chang, T.S.K., Snyder, S.H.: “Nitric Oxide: A Physiologic Mediator of Penile Erection.” Science, 257 (1992), 401-3.

  6. Burnett, A.L., Chan, D.W., Brendler, C.B., Walsh, P.C.: “The Value of Enzymatic Acid Phosphatase in the Staging of Localized Prostate Cancer.” J. Urol., 48 (1992), 1832-4.

  7. Burnett, A.L., Tillman, S.L., Chang, T.S.K., Epstein, J.I., Lowenstein, C.J., Bredt, D.S., Snyder, S.H., Walsh, P.C.: “Immunohistochemical Localization of Nitric Oxide Synthase in the Autonomic Innervation of the Human Penis. ” J. Urol., 150 (1993), 73 -6.

  8. Burnett, A.L., Epstein, J.I., Gearhart, J.P.: “Spectrum of Differentiation in Pediatric Epithelial Tumors of Kidney: Report of Two Cases.” Urology, 42,1 (1993), 93-8.

  9. Steiner, M.S., Burnett, A.L., Brooks, J.D., Brendler, C.B., Stutzman, R.E., Carter, H.B.: “Tubularized Neourethra Following Radical Retropubic Prostatectomy.” J. Urol., 150(1993), 407-10.

  10. Burnett, A.L., Brendler, C.B.: “Femoral Neuropathy Following Major Pelvic Surgery: Etiology and Prevention.” J. Urol., 151 (1994), 163 -5.

  11. Burnett, A.L., Ricker, D.D., Chamness, S.L., Maguire, M.P., Crone, J.K., Bredt, D.S., Snyder, S.H., Chang, T. S.K.: “Localization of Nitric Oxide Synthase in the Reproductive Organs of the Male Rat.” Biol. Reprod., 52 (1995), 1-7.

  12. Burnett, A.L., Saito, S., Maguire, M.P., Yamaguchi, H., Chang, T.S.K., Hanley, D.F.: “Localization of Nitric Oxide Synthase in Spinal Nuclei Innervating Pelvic Ganglia.” J. Urol., 153 (1995), 212-7.

  13. Gearhart, J.P., Burnett, A.L., Owen, J.H.: “Measurement of Pudendal Evoked Potentials During Feminizing Genitoplasty: Technique and Applications.” J. Urol., 153 (1995), 486-7.

  14. Burnett, A.L.: “The Role of Nitric Oxide in the Physiology of Erection.” Biol. Reprod., 52 (1995), 485-9.

  15. Burnett, A.L., Maguire, M.P., Chamness, S.L., Ricker, D.D., Takeda, M., Lepor, H., Chang, T. S.K.: “Characterization and Localization of Nitric Oxide Synthase in the Human Prostate.” Urology, 45,3 (1995), 435-9.

  16. Takeda, M., Tang, R., Shapiro, E., Burnett, A.L., Lepor, H.: “Effects of Nitric Oxide on Human and Canine Prostates.” Urology, 45,3 (1995), 440-6.

  17. Burnett, A.L., Allen, R.P., Tempany, C.M., Dover, G.J., Brendler, C.B.: “Evaluation of Erectile Function in Men with Sickle Cell Disease.” Urology, 45,4 (1995), 657-63.

  18. Chamness, S.L., Ricker, D.D., Crone, J.K., Dembeck, C.L., Maguire, M.P., Burnett, A.L., Chang, T. S.K.: “The Effect of Androgen on Nitric Oxide Synthase in the Male Reproductive Tract of the Rat.” 4 Fertil. Steril., 63,5 (1995), 1101-7.

  19. Burnett, A.L.: “Nitric Oxide Control of Lower Genitourinary Tract Functions: A Review.” Urology, 45, 6 (1995),1071-83.

  20. Burnett, A.L., Nelson, R.J., Calvin, D.C., Liu, J., Demas, G.E., Klein, S.L., Kriegsfeld, L.J., Dawson, T.M., Snyder, S.H.: “Nitric Oxide Dependent Penile Erection in Mice Lacking Neuronal Nitric Oxide Synthase.” Mol. Med., 2,3 (1996), 288-96.

  21. Burnett, A.L., Donowitz, M., Marshall, F.F.: “Inhibition of Transport Processes of lntestinal Segments Following Augmentation Enterocystoplasty in Rats.” J. Urol., 156 (1996), 1872-5.

  22. Wesselmann, U., Burnett, A.L.: “Treatment of Neuropathic Testicular Pain.” Neurology (Suppl.) (1996), 206.

  23. Burnett, A.L.: “Fascia Lata in Penile Reconstructive Surgery: A Reappraisal of the Fascia Lata Graft.” Plas. Reconstr. Surg., 99,4 (1997), 1061-7.

  24. Burnett, A.L.: “Nitric Oxide in the Penis: Physiology and Pathology.” J. Urol., 157 (1997), 320-4.

  25. Padma-Nathan, H., Hellstrom, W.J.G., Kaiser, F.E., et al, for the Medicated Urethral System for Erection (MUSE) Study Group.: “Treatment of Men with Erectile Dysfunction with Transurethral Alprostadil.” N. Engl. J. Med., 336 (1997), 1-7.

  26. Han, M., Burnett, A.L., Fishman, E.K., Marshall, F.F.: “The Natural History and Treatment of Adrenal Myelolipoma.” J. Urol., 157 (1997), 1213-6.

  27. Burnett, A.L., Calvin, D.C., Chamness, S.L., Liu, J.-X., Dawson, V.L., Dawson, T.M., Snyder, S.H.: “Urinary Bladder-Urethral Sphincter Dysfunction in Mice with Targeted Disruption of Neuronal Nitric Oxide Synthase Models Idiopathic Voiding Disorders in Humans.” Nature Med., 3 (1997), 571-4.

  28. Burnett, A.L., Calvin, D.C., Silver, R.I., Peppas, D.S., Docimo, S.G.: “Immunohistochemical Description of Nitric Oxide Synthase Isoforms in Human Clitoris.” J. Urol., 158 (1997), 75-8.

  29. Wesselmann, U., Burnett, A.L., Heinberg, L.J.: “The Urogenital and Rectal Pain Syndromes.” Pain 73 (1997), 269-94.

  30. Burnett, A.L., Johns, D.G., Kriegsfeld, L.J., Klein, S.L., Calvin, D.C., Demas, G.E., Schramm, L.P., Tonegawa, S., Nelson, R.J.,, Snyder, S.H., Poss, K.D.: “Ejaculatory Abnormalities in Mice with Targeted Disruption of Heme Oxygenase-2.” Nature Med. 4 (1998), 84-7.

  31. Burnett, A.L.: “Erectile Dysfunction: A Practical Approach For Primary Care.” Geriatrics 53 (1998), 34-48.

  32. Crone, J.K., Burnett, A.L., Chamness, S.L., Strandberg, J.D., Chang, T. S.: “Neuronal Nitric Oxide Synthase in the Canine Prostate: Aging, Sex Steroid and Pathology Correlations.” J. Androl. 19 (1998), 358-64.

  33. Burnett, A.L., Mostwin, J.L.: “In Situ Anatomical Study of the Male Urethral Sphincteric Complex: Relevance to Urinary Continence Preservation Following Major Pelvic Surgery.” J. Urol. 160 (1998), 1301-6.

  34. Klein, S.L., Carnovale, D., Burnett, A.L., Wallach, E.E., Zacur, H.A., Dawson, V.L., Nelson, R.J., Dawson, T.M.: “Impaired Ovulation in Mice with Targeted Deletion of the Neuronal Isoform of Nitric Oxide Synthase.” Mol. Med. 4 (1998), 658-64.

  35. Althof, S.E., Corty, E.W., Levine, S.B., Seftel, A., Levine, F., Burnett, A.L., McVary, K., Stecher, V.: “The EDITS: The Development of Questionnaires for Evaluating Satisfaction with Treatments for Erectile Dysfunction.” Urology 53 (1999), 793-9.

  36. Burnett, A.L., Wesselmann, U.: “History of the Neurobiology of the Pelvis.” Urology 53 (1999), 1082-9.

  37. Burnett, A.L., Wesselmann, U.: “Neurobiology of the Pelvis and Perineum: Principles for a Practical Approach.” J. Pelvic Surgery 5 (1999), 224-32.

  38. Jarow, J.P., Burnett, A.L., Geringer, A.M.: “Clinical Efficacy of Sildenafil Citrate Based upon Etiology and Response to Prior Treatment.” J. Urol. 162 (1999), 722-5.

  39. Drazen, D.L., Klein, S.L., Burnett, A.L., Wallach, E.E., Crone, J.K., Huang, P.L., Nelson, R.J.: “Reproductive Function in Female Mice Lacking the Gene for Endothelial Nitric Oxide Synthase.” Nitric Oxide: Biol. Chem. 3, 5 (1999), 366-74.

  40. Kriegsfeld, L.J., Demas, GE., Burnett, A.L., Nelson, R.J.: “Ejaculatory Abnormalities in Mice Lacking the Gene for Endothelial Nitric Oxide Synthase (eNOS-/-).” Physiol. Behav. 67 (1999), 561-6.

  41. Burnett, A.L.: “Oral Pharmacotherapy for Erectile Dysfunction: Current Perspectives.” Urology 54 (1999), 561-6.

  42. Sezen, S. F., Burnett, A.L.: “Intracavernosal Pressure Monitoring in Mice: Responses to Electrical Stimulation of the Cavernous Nerve and to Intracavernosal Drug Administration.” J. Androl. 21 (2000), 311-5.

  43. Basson, R., Berman, J., Burnett, A., et al.: “Report of the International Consensus Development Conference on Female Sexual Dysfunction: Definitions and Classifications.” J. Urol. 163 (2000), 888-93.

  44. Rowland, D.L., Burnett, A.L.: “Pharmacotherapy in the Treatment of Male Sexual Dysfunction.” J. Sex Research 37 (2000), 226-43.

  45. Walsh, P.C., Marschke, P., Ricker, D., Burnett, A.L.: “Patient-Reported Urinary Continence and Sexual Function Following Anatomic Radical Prostatectomy.” Urology 55 (2000), 58-61.

  46. Walsh, P.C., Marschke, P., Ricker, D., Burnett, A.L.: “Use of Intraoperative Video Documentation to Improve Sexual Function Following Radical Retropubic Prostatectomy.” Urology 55 (2000), 62-7.

  47. Gonzalez-Cadavid, N.F., Burnett, A.L., Magee, T.R., Zeller, C.B., Vernet, D., Smith, N., Gitter, J., Rajfer, J.: “Expression of Penile Neuronal Nitric Oxide Synthase Variants in the Rat and Mouse Penile Nerves.” Biol. Reprod. 63 (2000), 704-14.

  48. Burnett, A.L., Allen, R.P., Davis, D.M. Wright, D.C., Trueheart, I.N., Chance, B.: “Near Infrared Spectrophotometry for the Diagnosis of Vasculogenic Erectile Dysfunction.” Int. J. Impotence Res. 12 (2000), 247-54.

  49. Burnett, A.L.: “Novel Pharmacological Approaches in the Treatment of Erectile Dysfunction.” World J. Urol. 19 (2001), 57-66.

  50. Meldrum, K.K., Meldrum, D.R., Sezen, S.F., Crone, J.K., Burnett, A.L.: “Heat Shock Prevents Simulated Ischemia-Induced Apoptosis in Renal Tubular Cells Via a PKC-dependent Mechanism.” Am. J. Physiol. Regul. Integr. Comp. Physiol. 281 (2001), R359-64.

  51. Meldrum, K.K., Meldrum, D.R., Hile, K.L, Burnett, A.L., Harken, A.H.: “A Novel Model of Ischemia in Renal Tubular Cells Which Closely Parallels in Vivo Injury.” J. Surg. Res. 99 (2001), 288-293.

  52. Sezen, S.F., Hoke, A., Burnett, A.L., Snyder, S.H.: “Immunophilin Ligand FK506 is Neuroprotective for Penile Innervation.” Nature Med. 7 (2001), 1073-4.

  53. Palese, M.A., Burnett, A.L.: “Corporoplasty Using Pericardium Allograft (Tutoplast) with Complex
    Penile Prosthesis Surgery.” Urology 58 (2001), 1049-52.

  54. Akingba, A.G., Burnett, A.L.: “Endothelial Nitric Oxide Synthase Protein Expression, Localization, and Activity in the Penis of the Alloxan-Induced Diabetic Rat.” Mol. Urol. 5 (2001), 189-97.

  55. Burnett, A.L., Chang, A.G., Crone, J.K., Huang, P.L., Sezen, S.F.: “Non-Cholinergic Penile Erection in Mice Lacking the Gene for Endothelial Nitric Oxide Synthase.” J. Androl. 23 (2002), 92-7.

  56. Hurt, K.J, Musicki, B., Palese, M.A., Crone, J.K., Becker, R.E., Moriarity, J.L., Snyder, S.H., Burnett, A.L.: “Akt-Dependent Phosphorylation of Endothelial Nitric Oxide Synthase Mediates Penile Erection.” Proc. Natl. Acad. Sci. 99 (2002), 4061-6.

  57. Barouch, L.A., Harrison, R.W., Skaf, M.M., Rosas, G.O., Cappola, T.P., Kobeissi, Z.A., Hobai, I.A., Lemmon, C.A., Burnett, A.L., O‟Rourke, B., Rodriguez, E.R., Huang, P.L., Lima, J.A.C., Berkowitz, D.E., Hare, J.M.: “Nitric Oxide Regulates the Heart by Spatial Confinement of Nitric Oxide Synthase Isoforms.” Nature 416 (2002), 337-9.

  58. Meldrum, K.K., Hile, K., Meldrum, D.R., Crone, J.A., Gearhart, J.P., Burnett, A.L.: “Simulated Ischemia Induces Renal Tubular Cell Apoptosis Through a Nuclear Factor-KappaB Dependent Mechanism.” J. Urol. 168 (2002), 248-52.

  59. Carson, C.C., Burnett, A.L., Levine, L.A., Nehra, A.: “The Efficacy of Sildenafil Citrate in Clinical Populations.” Urology 60 (2002), 12-27.

  60. Burnett, A.L.: “Nitric Oxide Regulation of Penile Erection: Biology and Therapeutic Implications.” J. Androl. 23 (2002), S20-S26.

  61. Burnett, A.L., Truss, M.C.: “Mediators of the Female Sexual Response: Pharmacotherapeutic Implications.” World J. Urol. 20 (2002), 101-105.

  62. Zhou, L., Burnett, A.L., Huang, P.L., Becker, L.C., Kuppusamy, P., Kass, D.A., Donahue, J.K., Proud, D., Sham, J.S.K., Dawson, T.M., Xu, K.Y.: “Lack of Nitric Oxide Synthase Depresses Ion Transporting Enzyme Function in Cardiac Muscle.” Biochem. Biophys. Res. Commun. 294 (2002), 1030-35.

  63. Derogatis, L.R., Rosen, R., Leiblum, S., Burnett, A.L., Heiman, J.: “The Female Sexual Distress Scale (FSDS): Initial Validation of a Standardized Scale for Assessment of Sexually Related Personal Distress in Women.” J. Sex. Marital. Ther. 28 (2002), 317-30.

  64. Sezen, S.F., Blackshaw, S., Steiner, J.P., Burnett, A.L.: “FK506 Binding Protein 12 is Expressed in Rat Penile Innervation and Upregulated after Cavernous Nerve Injury.” Int. J. Impotence Res. 14 (2002), 506-12.

  65. Magee, T.R., Zeller, C.B., Ferrini, M.G., Davila, H., Vernet, D., Sun, J., Burnett, A.L., Lalani, R., Rajfer, J., Gonzalez-Cadavid, N.F.: “The Protein Inhibitor of NOS (PIN) and the NMDA Receptor are Expressed in the Rat and Mouse Penile Nerves and Co-localize with Penile Neuronal NOS (PnNOS).” Biol. Reprod. 68 (2003), 478-88.

  66. Meldrum, K.K., Burnett, A.L., Meng, X., Misseri, R., Shaw, M.B.K., Gearhart, J.P., Meldrum, D.R.: “Liposomal Delivery of Heat Shock Protein 72 into Renal Tubular Cells Blocks Nuclear Factor-Kappa B Activation, Tumor Factor Necrosis-Alpha Production, and Subsequent Ischemia-Induced Apoptosis.” Circ. Res. 92 (2003), 294-299.

  67. Burnett, A.L.: “Rationale for Cavernous Nerve Restorative Therapies to Preserve Erectile Function after Radical Prostatectomy.” Urology 61 (2003), 491-497.

  68. Burnett, A.L.: “Pathophysiology of Priapism: Dysregulatory Erection Physiology Thesis.” J. Urol. 170 (2003), 26-34.

  69. Burnett, A.L.: “Neuroprotection and Nerve Grafts in the Treatment of Neurogenic Erectile Dysfunction.” J. Urol. 170 (2003), S31-S34.

  70. Burnett, A. L.: “Strategies to Promote Recovery of Cavernous Nerve Function after Radical Prostatectomy.” World J. Urol. 20 (2003), 337-342.

  71. Barouch, L.A., Cappola, T.P., Harrison, R.W., Crone, J.K., Rodriguez, E.R., Burnett, A.L., Hare,J.M.: “Combined Loss of Neuronal and Endothelial Nitric Oxide Synthase Causes Premature Mortality and Age-Related Hypertrophic Cardiac Remodeling in Mice.” J. Mol. Cell. Cardiol. 35 (2003), 637-644.

  72. Gonzalgo, M.L., Brotzman, M., Trock, B.J., Geringer, A.M., Burnett, A.L., Jarow, J.P.: “Clinical Efficacy of Sildenafil Citrate and Predictors of Long-term Response.” J.Urol. 170 (2003), 503-506.

  73. Palese, M.A., Crone, J.K., Burnett, A.L.: “A Castrated Mouse Model of Erectile Dysfunction.” J. Androl. 24 (2003), 699-703.

  74. Burnett, A.L.: “Priapism Pathophysiology: Clues to Prevention.” Int. J. Impot. Res. 15 Suppl 5 (2003), S80-S85.

  75. Burnett, A.L.: “Neurophysiology of Erectile Function: Androgenic Effects.” J. Androl. 24 (2003), S2-S5.

  76. Xu, K.Y., Kuppusamy, S.P., Wang, J.Q., Li, H., Cui, H., Dawson, T.M., Huang, P.L., Burnett, A.L., Kuppusamy, P., Becker, L.C.: “Nitric Oxide Protects Cardiac Sarcolemmal Membrane Enzyme Function and Ion Active Transport against Ischemia-induced Inactivation.” J. Biol. Chem. 278 (2003), 41798-41803.

  77. Burnett, A.L., Becker, R.E.: “Immunophilin Ligands Promote Penile Neurogenesis and Erection Recovery after Cavernous Nerve Injury.” J. Urol. 171 (2004), 495-500.

  78. Musicki, B., Palese, M.A., Crone, J.K., Burnett, A.L.: “Phosphorylated Endothelial Nitric Oxide Synthase Mediates Vascular Endothelial Growth Factor-Induced Penile Erection.” Biol. Reprod. 70 (2004), 282-289.

  79. Montorsi, F., Briganti, A., Salonia, A., Rigatti, P., Burnett, A.L.: “Current and Future Strategies for Preventing and Managing Erectile Dysfunction following Radical Prostatectomy.” Eur. Urol. 45 (2004), 123-133.

  80. Burnett, A.L.: “The Impact of Sildenafil on Molecular Science and Sexual Health.” Eur. Urol. 46(2004), 9-14.

  81. Burnett, A.L.: “Novel Nitric Oxide Signaling Mechanisms Regulate the Erectile Response.” Int. J. Impot. Res. 16 (2004), S15-S19.

  82. Champion, H.C., Bivalacqua, T.J., Takimoto, E., Kass, D.A., Burnett, A.L.: “Phosphodiesterase-5A Dysregulation in Penile Erectile Tissue is a Mechanism of Priapism.” Proc. Natl. Acad. Sci. 102 (2005), 1661-1666.

  83. Burnett, A.L.: “Vasoactive Pharmacotherapy to Cure Erectile Dysfunction: Fact or Fiction?” Urology 65 (2005), 224-230.

  84. Rowland, D.L., Thornton, J.A., Burnett, A.L.: “Recognizing the Risk of Erectile Dysfunction in a Urology Clinic Practice.” BJU Int. 95 (2005), 1034-1038.

  85. Musicki, B., Kramer, M.F., Becker, R.E., Burnett, A.L.: “Age-Related Changes in Phosphorylation of Endothelial Nitric Oxide Synthase in the Rat Penis.” J. Sex. Med. 2 (2005), 347-357.

  86. Burnett, A.L., Kramer, M.F., Dalrymple, S., Isaacs, J.T.: “Nonimmunosuppressant Immunophilin Ligand GPI-1046 Does Not Promote in Vitro Growth of Prostate Cancer Cells.” Urology. 65 (2005), 1003-1007.

  87. Burnett, A.L.: “Erectile Dysfunction Following Radical Prostatectomy.” JAMA. 293 (2005), 2648-2653.

  88. Musicki, B., Champion, H.C., Becker, R.E., Liu, T., Kramer, M.F., Burnett, A.L.: “Erection Capability is Potentiated by Long-Term Sildenafil Treatment: Role of Blood Flow-Induced Endothelial Nitric Oxide Synthase Phosphorylation.” Mol. Pharmacol. 68 (2005), 226-232.

  89. Kostis, J.B, Jackson, G., Rosen, R., Barrett-Connor, E., Billups, K., Burnett, A.L., et al: “Sexual Dysfunction and Cardiac Risk (the Second Princeton Consensus Conference).” Am. J. Cardiol. 96 (2005), 313-321.

  90. Burnett, A.L.: “Nitric Oxide-Based Therapy for Erectile Disorders.” Drug Discovery Today: Therapeutic Strategies 2 (2005), 25-30.

  91. Musicki, B., Kramer, M.F., Becker, R.E., Burnett, A.L.: “Inactivation of Phosphorylated Endothelial Nitric Oxide Synthase (Ser-1177) by O-GlcNAc in Diabetes-Associated Erectile Dysfunction.” Proc. Natl. Acad. Sci. 102 (2005), 11870-11875.

  92. Musicki, B., Champion, H.C., Becker, R.E., Kramer, M.F., Liu, T., Sezen, S.F., Burnett, A.L.: “In Vivo Analysis of Chronic Phosphodiesterase-5 Inhibition with Sildenafil in Penile Erectile Tissues: No Tachyphylaxis Effect.” J. Urol. 174 (2005), 1493-1496.

  93. Shabsigh, R., Burnett, A.L., Eardley, I., Sharlip, I.D., Ellsworth, P.I., Garcia, C.S., Natanegara, F., Ahuja, S.: “Time from Dosing to Sexual Intercourse Attempts in Men Taking Tadalafil in Clinical Trials.” B.J.U. Int. 96 (2005), 857-863.

  94. Burnett, A.L.: “Therapy Insight: Priapism associated with Hematologic Dyscrasias.” Nature Clin. Pract. Urol. 2 (2005), 449-456.

  95. Allaf, M.E., Hoke, A., Burnett, A.L.: “Erythropoietin Promotes the Recovery of Erectile Function following Cavernous Nerve Injury.” J. Urol. 174 (2005), 2060-2064.

  96. Burnett, A.L.: “Metabolic Syndrome, Endothelial Dysfunction, and Erectile Dysfunction: Association and Management.” Curr. Urol. Rep. (2005), 470-475.

  97. Burnett, A.L., Musicki, B.: “The Nitric Oxide Signaling Pathway in the Penis.” Curr. Pharm. Des. 11 (2005), 3987-3994.

  98. Bivalacqua, T.J., Musicki, B., Usta, M.F., Champion, H.C., Kadowitz, P.J., Burnett, A.L., Hellstrom, W.J.G.: “Endothelial Nitric Oxide Synthase Gene Therapy for Erectile Dysfunction.” Curr. Pharm. Des. 11 (2005), 4059-4068.

  99. Burnett, A.L.: “Phosphodiesterase 5 Mechanisms and Therapeutic Applications.” Am. J. Cardiol. 96 (2005), 29-31.

  100. Burnett, A.L.: “Neuromodulatory Therapy with Applications for the Radical Pelvic Surgery Patient.” Current Sexual Health Reports 2 (2005), 69-73.

  101. Jin, L., Liu, T., Lagoda, G.A., Champion, H.C., Bivalacqua, T.J., Burnett, A.L.: “Elevated RhoA/Rho-kinase Activity in the Aged Rat Penis: Mechanism for Age-Associated Erectile Dysfunction.” FASEB J. 20 (2006), 536-538.

  102. Jin, L., Burnett, A.L.: “RhoA/Rho-kinase in Erectile Tissue: Mechanisms of Disease and Therapeutic Insights.” Clin. Sci. 110 (2006), 153-165.

  103. Montorsi, F., Briganti, A., Salonia, A., Rigatti, P., Burnett, A.L.: “Can Phosphodiesterase Type 5 Inhibitors Cure Erectile Dysfunction?” Eur. Urol. 49 (2006), 979-986.

  104. Musicki, B., Burnett, A.L.: “eNOS Function and Dysfunction in the Penis.” Exp. Biol. Med. 231 (2006), 154-165.

  105. Blaivas, J.G., Burnett, A.L., Wein, A.J.: “Current Trends in Lower Urinary Tract Health Highlights from Annual Advances in Genitourinary Health: A Scientific Update.” J. Urol. 175 (2006), S3-S4.

  106. Burnett, A.L., Wein, A.J.: “Benign Prostatic Hyperplasia in Primary Care: What You Need to Know.” J. Urol. 175 (2006), S19-S24.

  107. Burnett, A.L.: “Erectile Dysfunction.” J. Urol. 175 (2006), S25-S31.

  108. Hurt, K.J., Sezen, S.F., Champion, H.C., Crone, J.K., Palese, M.A., Huang, P.L., Sawa, A., Luo, X., Musicki, B., Snyder, S.H., Burnett, A.L.: “Alternatively Spliced Neuronal Nitric Oxide Synthase Mediates Penile Erection.” Proc. Natl. Acad. Sci. 103 (2006), 3440-3443.

  109. Burnett, A.L., Musicki, B., Jin, L., Bivalacqua, T.J.: “Nitric Oxide/Redox-Based Signalling as a Therapeutic Target for Penile Disorders.” Expert Opin. Ther. Targets 10 (2006), 445-457.

  110. Burnett, A.L., Bivalacqua, T.J., Champion, H.C., Musicki, B.: “Long-Term Oral Phosphodiesterase 5 Inhibitor Therapy Alleviates Recurrent Priapism.” Urology 67 (2006), 1043-1048.

  111. Musicki, B., Burnett, A.L.: “Endothelial Dysfunction in Diabetic Erectile Dysfunction.” Int. J. Impot. Res. 19 (2006), 129-138.

  112. Burnett, A.L.: “Nitric Oxide in the Penis-Science and Therapeutic Implications from Erectile Dysfunction to Priapism.” J. Sex. Med. 3 (2006), 578-582.

  113. Burnett, A.L., Lue, T.: “Neuromodulatory Therapy to Improve Erectile Function Recovery Outcomes after Pelvic Surgery.” J. Urol. 176 (2006), 882-887.

  114. Bivalacqua, T.J., Burnett, A.L.: “Priapism: New Concepts in the Pathophysiology and New Treatment Strategies.” Curr. Urol. Rep. 7 (2006), 497-502.

  115. Bivalacqua, T.J., Burnett, A.L., Hellstrom, W., Champion, H.C.: “Overexpression of Arginase in the Aged Mouse Penis Impairs Erectile Function and Decreases NOS3 Activity: Influence of In Vivo Gene Therapy of Anti-Arginase.” Am. J. Physiol. Heart Circ. Physiol. 292 (2006), H1340-H1351.

  116. Rosen, R.C., Catania, J.A., Ehrhardt, A.A., Burnett, A.L., Lue, T.F., McKenna, K., et al.: “The Bolger Conference on PDE-5 Inhibition and HIV Risk: Implications for Health Policy and Prevention.” J. Sex. Med. 36 (2006), 960-975.

  117. Burnett, A.L., Bivalacqua, T.J., Champion, H.C., Musicki, B.: “Feasibility of the Use of Phosphodiesterase Type 5 Inhibitors in a Pharmacologic Prevention Program for Recurrent Priapism.” J. Sex. Med. 3 (2006), 1077-1084.

  118. Burnett, A.L.: “The Role of Nitric Oxide in Erectile Dysfunction: Implications for Medical Therapy.” J. Clin. Hypertens. 8 (2006), 53-62.

  119. Bivalacqua, T.J., Liu, T., Musicki, B., Champion, H.C., Burnett, A.L.: “Endothelial Nitric Oxide Synthase Keeps Erection Regulatory Function Balance in the Penis.” Eur. Urol. 51 (2007), 1732-1740.

  120. Valentine, H., Chen, Y., Guo, H., McCormick, J., Wu, Y., Sezen, S.F., Hoke, A., Burnett, A.L., Steiner, J.P.: “Neuroimmunophilin Ligands Protect Cavernous Nerves after Crush Injury in the Rat: New Experimental Paradigms.” Eur. Urol. 51 (2007), 1724-1731.

  121. Fried, N.M., Rais-Bahrami, S., Lagoda, G.A., Chung, Y., Burnett, A.L., Su, L.M.: “Imaging the Cavernous Nerves in the Rat Prostate Using Optical Coherence Tomography.” Lasers. Surg. Med. 39 (2007), 36-41.

  122. Cookson, M.S., Aus, G., Burnett, A.L., Canby-Hagino, E.D., D‟Amico, A.V., Dmochowski, R.R., Eton, D.T., Forman, J.D., Goldenberg, S.L., Hernandez, J., Higano, C.S., Kraus, S.R., Moul, J.W., Tangen, C., Thrasher, J.B., Thompson, I.: “Variation in the Definition of Biochemical Recurrence in Patients Treated for Localized Prostate Cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel Report and Recommendations for a Standard in the Reporting of Surgical Outcomes.” J. Urol. 177 (2007), 540-545.

  123. Selvin, E., Burnett, A.L., Platz, E.A.: “Prevalence and Risk Factors for Erectile Dysfunction in the US.” Am. J. Med. 120 (2007), 151-157.

  124. Burnett, A.L., Musicki, B., Bivalacqua, T.J.: “Molecular Science of Priapism.” Curr. Sex. Health Rep. 4 (2007), 9-14.

  125. Derogatis, L.R., Burnett, A.L.: “Key Methodological Issues in Sexual Medicine Research (CME).”
    J. Sex. Med. 4 (2007), 527-537.

  126. Thompson, I., Thrasher, J.B., Aus, G., Burnett, A.L., Canby-Hagino, E.D., Cookson, M.S., D‟Amico, A.V., Dmochowski, R.R., Eton, D.T., Forman, J.D., Goldenberg, S.L., Hernandez, J., Higano, C.S., Kraus, S.R., Moul, J.W., Tangen, C.M.; Prostate Cancer Clinical Guideline Update Panel: “Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update.” J. Urol. 177 (2007), 2106-2131.

  127. Burnett, A.L., Aus, G., Canby-Hagino, E.D., Cookson, M.S., D‟Amico, A.V., Dmochowski, R.R., Eton, D.T., Forman, J.D., Goldenberg, S.L., Hernanadez, J., Higano, C.S., Kraus, S., Liebert, M., Moul, J.W., Tangen, C., Thrasher, J.B., Thompson, I.; American Urological Association Prostate Cancer Guideline Update Panel: “Erectile Function Outcome Reporting after Clinically Localized Prostate Cancer Treatment.” J. Urol. 178 (2007), 597-601.

  128. Lagoda, G., Jin, L., Lehrfeld, T.J., Liu, T., Burnett, A.L.: “FK506 and Sildenafil Promote Erectile Function Recovery after Cavernous Nerve Injury through Antioxidative Mechanisms.” J. Sex. Med. 4 (2007), 908-916.

  129. Liu, T., Allaf, M.E., Lagoda, G., Burnett, A.L.: “Erythropoietin Receptor Expression in the Human Urogenital Tract: Immunolocalization in the Prostate, Neurovascular Bundle and Penis.” BJU. Int. 100 (2007), 1103-1106.

  130. Burnett, A.L.: “Molecular Pharmacotherapeutic Targeting of PDE5 for Preservation of Penile Health.” J. Androl. 29 (2007), 3-14 .

  131. Glina, S., Burnett, A.L., Becher, E., Brock, G., Hellstrom, W.: “Priapism: Reasons for Failure by Frank Hinman, Jr..” J. Sex. Med. 4 (2007), 1539-1543.

  132. Burnett, A.L., Bivalacqua, T.J.: “Glucose-6-Phosphate Dehydrogenase Deficiency: An Etiology for Idiopathic Priapism?” J. Sex. Med. 5 (2007), 237-240.

  133. Burnett, A.L., Bivalacqua, T.J.: “Priapism: Current Principles and Practice.” Urol. Clin. North Am. 34 (2007), 631-642.

  134. Lagoda, G., Sezen, S.F., Liu, T., Höke, A., Burnett, A.L.: “FK506-Binding Protein Localizations in Human Penile Innervation.” BJU Int. 101 (2007), 604-609.

  135. Derogatis, L.R., Burnett, A.L.: “The Epidemiology of Sexual Dysfunctions.” J. Sex. Med. 5 (2007), 289-300.

  136. Fried, N.M., Rais-Bahrami, S., Lagoda, G.A., Chuang, Y., Su, L.M., Burnett, A.L.: “Identification and Imaging of the Nerves Responsible for Erectile Function in Rat Prostate, In Vivo, using Optical Nerve Stimulation and Optical Coherence Tomography.” IEEE Trans. Biomed. Eng. 13 (2007), 1641-1645.

  137. Jin, L., Burnett, A.L.: “NADPH Oxidase: Recent Evidence for its Role in Erectile Dysfunction.” Asian J. Androl. 10 (2008), 6-13.

  138. Strong, T.D., Gebska, M.A., Burnett, A.L., Champion, H.C., Bivalacqua, T.J.: “Endothelium-Specific Gene and Stem Cell-based Therapy for Erectile Dysfunction.” Asian J. Androl. 10 (2008), 14-22.

  139. Musicki, B., Liu, T., Strong, T., Jin, L., Laughlin, M.H., Turk, J.R., Burnett, A.L.: “Low-Fat Diet and Exercise Preserve eNOS Regulation and Endothelial Function in the Penis of Early Atherosclerotic
    Pigs: A Molecular Analysis.” J. Sex. Med. 5 (2008), 552-561.

  140. Strong, T.D., Gebska, M.A., Champion, H.C., Burnett, A.L., Bivalacqua, T.J.: “Stem and Endothelial Progenitor Cells in Erection Biology.” Int. J. Impot. Res. 120 (2008), 243-254.

  141. Fried, N.M., Lagoda, G.A., Scott, N.J., Su, L.M., Burnett, A.L.: “Noncontact Stimulation of the Cavernous Nerves in the Rat Prostate using a Tunable-Wavelength Thulium Fiber Laser.” J. Endourol. 22 (2008), 409-413.

  142. Rais-Bahrami, S., Levinson, A.W., Fried, N.M., Lagoda, G.A., Hristov, A., Chuang,Y., Burnett, A.L., Su, L.M.: “Optical Coherence Tomography of Cavernous Nerves: A Step Toward Real-time Intraoperative Imaging During Nerve-Sparing Radical Prostatectomy.” Urology. 72 (2008),198-204.

  143. Jin, L., Lagoda, G., Leite, R., Webb, R.C., Burnett, A.L.: “NADPH Oxidase Activation: A Mechanism of Hypertension-Associated Erectile Dysfunction.” J. Sex. Med. 5 (2008), 544-551.

  144. Burnett, A.L.: “Environmental Erectile Dysfunction: Can the Environment Really Be Hazardous to Your Erectile Health?” J. Androl. 29 (2008), 229-236.

  145. Canguven O, Burnett, A.L.: “The Effect of 5 Alpha-Reductase Inhibitors on Erectile Function.” J. Androl. 29 (2008), 514-523.

  146. Burnett, A.L., Teloken, P.E., Briganti, A., Whitehurst, T., Montorsi, F.: “Intraoperative Assessment of an Implantable Electrode Array for Cavernous Nerve Stimulation.” J. Sex. Med. 5 (2008), 1949-1954.

  147. Bivalacqua, T.J., Guzzo, T.J., Schaeffer, E.M., Gebska, M.A., Champion, H.C., Burnett, A.L., Gonzalgo, M.L.: “Application of Evicel to Cavernous Nerves of the Rat Does Not Influence Erectile Function in Vivo.” Urology 72 (2008), 1169-1173.

  148. Burnett, A.L., Allaf, M.E., Bivalacqua, T.J.: “Erythropoietin Promotes Erection Recovery after Nerve-Sparing Radical Prostatectomy: A Retrospective Analysis.” J. Sex. Med. 5 (2008), 2392-2398.

  149. Fried, N.M., Lagoda, G.A., Scott, N.J., Su, L.M., Burnett, A.L.: “Laser Stimulation of the Cavernous Nerves in the Rat Prostate, In Vivo: Optimization of Wavelength, Pulse Energy, and Pulse Repetition Rate.” Conf. Proc. IEEE Eng. Med. Biol. Soc. 1 (2008), 2777-2780.

  150. Burnett, A.L.: “Erectile Dysfunction Management for the Future.” J. Androl. 30 (2009), 391-396.

  151. Hatzimouratidis, K., Burnett, A.L., Hatzichristou, D., McCullough, A.R., Montorsi, F., Mulhall, J.P.: “Phosphodiesterase Type 5 Inhibitors in Postprostatectomy Erectile Dysfunction: A Critical Analysis of the Basic Science Rationale and Clinical Application.” Eur. Urol. 55 (2009), 334-347.

  152. Burnett, A.L., Strong, T.D., Trock, B.J., Jin, L., Bivalacqua, T.J., Musicki, B.: “Serum Biomarker Measurements of Endothelial Function and Oxidative Stress after Daily Dosing of Sildenafil in Type 2 Diabetic Men with Erectile Dysfunction.” J. Urol. 181 (2009), 245-251.

  153. Bivalacqua, T.J., Sussan, T.E., Gebska, M.A., Strong, T.D., Berkowitz, D.E., Biswal, S., Burnett, A.L., Champion, H.C.: “Sildenafil Inhibits Superoxide Formation and Prevents Endothelial Dysfunction in a Mouse Model of Secondhand Smoke Induced Erectile Dysfunction.” J. Urol. 181 (2009), 899-906.

  154. Burnett, A.L., Santiago, C.S. 3rd.: “Resolution of Recurrent Ischemic Priapism after Celiac Plexus
    Block: Case Report Evidence for its Neurogenic Origin?” J. Sex. Med. 6 (2009), 886-889.

  155. Burnett, A.L., Pierorazio, P.M.: “Corporal “Snake” Maneuver: Corporoglanular Shunt Surgical Modification for Ischemic Priapism.” J. Sex. Med. 6 (2009), 1171-1176.

  156. Musicki, B., Liu, T., Lagoda, G.A., Bivalacqua, T.J., Strong, T.D., Burnett, A.L.: “Endothelial Nitric Oxide Synthase Regulation in Female Genital Tract Structures.” J. Sex. Med. 6 Suppl 3 (2009), 247-253.

  157. Sezen, S.F., Lagoda, G., Burnett, A.L.: “Role of Immunophilins in Recovery of Erectile Function after Cavernous Nerve Injury.” J. Sex. Med. 6 Suppl 3 (2009), 340-346.

  158. Musicki, B., Ross, A.E., Champion, H.C., Burnett, A.L., Bivalacqua, T.J.: “Post-Translational Modification of Constitutive Nitric Oxide Synthase in the Penis.” J. Androl. 30 (2009), 352-362.

  159. Canguven, O., Lagoda, G., Sezen, S.F., Burnett, A.L.: “Losartan Preserves Erectile Function After Bilateral Cavernous Nerve Injury via Antifibrotic Mechanisms in Male Rats.” J. Urol. 181 (2009), 2816-2822.

  160. Lagoda, G., Sezen, S.F., Burnett, A.L.: “FK506 and Rapamycin Neuroprotect Erection and Involve Different Immunophilins in a Rat Model of Cavernous Nerve Injury.” J. Sex. Med. 6 (2009), 1914-1923.

  161. Burnett, A.L.: “Anxiety Disorders in Patients with Idiopathic Priapism: Risk Factor and Pathophysiologic Link?” J. Sex. Med. 6 (2009), 1712-1718.

  162. Bivalacqua, T.J., Musicki, B., Hsu, L.L., Gladwin, M.T., Burnett, A.L., Champion, H.C.: “Establishment of a Transgenic Sickle-Cell Mouse Model to Study the Pathophysiology of Priapism.” J. Sex. Med. 6 (2009), 2494-2504.

  163. Facio, F., Jr., Burnett, A.L.: “Penile Rehabilitation and Neuromodulation.” Scientific World Journal 9 (2009), 652-664.

  164. Canguven, O., Bailen, J., Fredriksson, W., Bock, D., Burnett, A.L.: “Combination of Vacuum Erection Device and PDE5 Inhibitors as Salvage Therapy in PDE5 Inhibitor Nonresponders with Erectile Dysfunction.” J. Sex. Med. 6 (2009), 2561-2567.

  165. Magheli, A., Burnett, A.L.: “Erectile Dysfunction following Prostatectomy: Prevention and Treatment.” Nat. Rev. Urol. 6 (2009), 415-427.

  166. Walz, J., Burnett, A.L., Costello, A.J., Eastham, J.A., Graefen, M., Guillonneau, B., Menon, M., Montorsi, F., Myers, R.P., Rocco, B., Villers, A.: “A Critical Analysis of the Current Knowledge of Surgical Anatomy Related to Optimization of Cancer Control and Preservation of Continence and Erection in Candidates for Radical Prostatectomy.” Eur. Urol. 57 (2010), 179-192.

  167. Musicki, B., Liu, T., Strong, T.D., Lagoda, G.A., Bivalacqua, T.J., Burnett, A.L.: “Post-translational Regulation of Endothelial Nitric Oxide Synthase (eNOS) by Estrogens in the Rat Vagina.” J. Sex. Med. 7 (2010), 1768-1777.

  168. Bivalacqua, T.J., Ross, A.E., Strong, T.D., Gebska, M.A., Musicki, B., Champion, H.C., Burnett, A.L.: “Attenuated Rho-A/Rho-kinase Signaling in Penis of Transgenic Sickle Cell Mice.” Urology 76 (2010), 510, e7-12.

  169. Musicki, B., Liu, T., Lagoda, G.A., Strong, T.D., Sezen, S.F., Johnson, J.M., Burnett, A.L.: “Hypercholesterolemia-Induced Erectile Dysfunction: Endothelial Nitric Oxide Synthase (eNOS) Upcoupling in the Mouse Penis by NAD(P)H Oxidase.” J. Sex. Med. 7 (2010), 3023-3032.

  170. Gratzke, C., Strong, T.D., Gebska, M.A., Champion, H.C., Stief, C.G. Burnett, A.L., Bivalacqua, T.J.: “Activated RhoA/Rho Kinase Impairs Erectile Function After Cavernous Nerve Injury in Rats.” J. Urol. 184 (2010), 2197-2204.

  171. Facio, F., Kashiwabuschi, R., Nishi, Y., Leao, R., McDonnell, P., Burnett, A.L.: “Benign Prostatic Hyperplasia. Clinical Treatment Can Complicate Cataract Surgery.” Int. Braz. J. Urol. 36 (2010), 563-570.

  172. Tozburun, S., Cilip, C.M., Lagoda, G.A., Burnett, A.L., Fried, N.M.: “Continuous-Wave Infrared Optical Nerve Stimulation for Potential Diagnostic Applications.” J. Biomed. Opt. 15 (2010), 055012.

  173. Burnett, A.L., Goldstein, I., Andersson, K.E., Argiolas, A., Christ, G., Park, K., Xin, Z.C.: “Future Sexual Medicine Physiological Treatment Targets.” J. Sex. Med. 7 (2010), 3269-3304.

  174. Montorsi, F., Adaikan, G., Becher, E., Giuliano, F., Khoury, S., Lue, T.F., Sharlip, I., Althof, S.E., Andersson, K.E., Brock, G., Broderick, G., Burnett, A.L., Buvat, J., Dean, J., Donatucci, C., Eardley, I., Fugl-Meyer, K.S., Goldstein, I., Hacket, G., Hatzichristou, D., Hellstrom, W., Incrocci, L., Jackson, G., Kadioglu, A., Levine, L., Lewis, R.W., Maggi, M., McCabe, M., McMahon, C.G., Montague, D., Montorsi, P., Mullhall, J., Pfaus, J., Porst, H., Ralph, D., Rosen, R., Rowland, D., Sadeghi-Nejad, H., Shabsigh, R., Stief, C., Vardi, Y., Wallen, K., Wasserman, M.: “Summary of the Recommendations on Sexual Dysfunctions in Men.” J. Sex. Med. 7 (2010), 3572-3588.

  175. Rowland, D.L., Georgoff, V.L., Burnett, A.L.: “Psychoaffective Differences between Sexually Functional and Dysfunctional Men in Response to a Sexual Experience.” J. Sex. Med. 8 (2011), 132-139.

  176. Musicki, B., Champion, H.C., Hsu, L.L., Bivalacqua, T.J., Burnett, A.L.: “Post-Translational Inactivation of Endothelial Nitric Oxide Synthase in the Transgenic Sickle Cell Mouse Penis.” J. Sex. Med. 8 (2011), 419-426.

  177. Pierorazio, P.M., Bivalacqua, T.J., Burnett, A.L.: “Daily Phosphodiesterase Type-5 Inhibitor Therapy as Rescue for Recurrent Ischemic Priapism after Failed Androgen Ablation.” J. Androl. 32 (2011), 371-374.

  178. Ferreira, J.M., Burnett, A.L., Rameau, G.A.: “Activity-Dependent Regulation of Surface Glucose Transporter-3.” J. Neurosci. 31 (2011), 1991-1999.

  179. Johnson, J.M., Bivalacqua, T.J., Lagoda, G.A., Burnett, A.L., Musicki, B.: “eNOS-Uncoupling in Age-Related Erectile Dysfunction.” Int. J. Impot. Res. 23 (2011), 43-48.

  180. Tajkarimi, K., Burnett, A.L.: “The Role of Genital Nerve Afferents in the Physiology of the Sexual Response and Pelvic Floor Function.” J. Sex. Med. 8 (2011), 1299-1312.

  181. Schaeffer, A.J., Burnett, A.L.: “Non-Surgical Interventions for Peyronie‟s Disease: 2011 Update.” J. Androl. 33 (2012), 3-14.

  182. Morrison, B.F., Burnett, A.L.: “Priapism in Hematological and Coagulative Disorders: An Update.” Nat. Rev. Urol. 8 (2011), 223-230.

  183. Segal, R., Burnett, A.L.: “Erectile Preservation following Radical Prostatectomy.” Ther. Adv. Urol. 3 (2011), 35-46.

  184. Burnett, A.L., Bivalacqua, T.J.: “Priapism: New Concepts in Medical and Surgical Management.” Urol. Clin. North Am. 38 (2011), 185-194.

  185. Bivalacqua, T.J., Musicki, B., Kutlu, O., Burnett, A.L.: “New Insights into the Pathophysiology of Sickle Cell Disease-Associated Priapism.” J. Sex. Med. 9 (2012), 79-87.

  186. Burnett, A.L.: “Sexual Health Outcomes Improvement in Sickle Cell Disease: A Matter of Health Policy?” J. Sex. Med. 9 (2012), 104-113.

  187. Tozburun, S., Lagoda, G.A., Burnett, A.L., Fried, N.M.: “Continuous-Wave Laser Stimulation of the Rat Prostate Cavernous Nerves using a Compact and Inexpensive All Single Mode Optical Fiber System.” J. Endourol. 25 (2011), 1727-1731.

  188. Kutlu, O., Ross, A.E., Schaeffer, E.M., Gratzke, C., Stief, C.G., Strong, T.D., Burnett, A.L., Hedlund, P., Bivalacqua, T.J.: “Increased Expression of Nestin in the Major Pelvic Ganglion Following Cavernous Nerve Injury.” Int. J. Impot. Res. 24(2012), 84-90.

  189. Lagoda, G.A., Xie, Y., Sezen, S.F., Hurt, K. J., Liu, L, Musicki, B., Burnett, A.L.: “FK506 Neuroprotection after Cavernous Nerve Injury Is Mediated by Thioredoxin and Glutathione Redox Systems.” J. Sex. Med. 8 (2011) 3325-3334.

  190. Sezen, S.F., Lagoda, G.A., Burnett A.L.: “Neuronal Nitric Oxide Signaling Regulates Erection Recovery after Cavernous Nerve Injury.” J. Urol. 187 (2012), 757-63.

  191. Burnett, A.L.: “Surgical Management of Ischemic Priapism.” J. Sex. Med. 9 (2012), 114-20.

  192. Calenda, G., Strong, T.D., Pavlovich, C.P., Schaeffer, E.M., Burnett, A.L., Yu, W., Davies, K.P., Bivalacqua, T.J.: “Whole Genome Microarray of the Major Pelvic Ganglion after Cavernous Nerve Injury: New Insights into Molecular Profile Changes after Nerve Injury.” BJU Int. 109 (2012), 1552-64.

  193. Segal R., Burnett A.L.: “Avanafil for the Treatment of Erectile Dysfunction.” Drugs Today. 48 (2012), 7-15.

  194. Tozburun S., Lagoda G.A., Burnett A.L., Fried, N.M.: “Subsurface Near-Infrared Laser Stimulation of the Periprostatic Cavernous Nerves.”J. Biophotonics. 5(2012), 793-800.

  195. Rowland, D.L., Lechner, K.H., Burnett, A.L.: “Factors Contributing to Psychoaffective Differences among Men with Sexual Dysfunction in Response to a Partnered Sexual Experience.” J. Sex Marital Ther. (2012), 115-27.

  196. Burnett A.L., Sharlip I.D.: “Standard Operating Procedures for Priapism.” J. Sex. Med. 10(2013), 180-94.

  197. Segal, R., Hannon, J.L., Lu, X., Kutlu, O., Burnett, A.L., Champion, H.C., Kim, J.H., Steppan, J., Berkowitz, D.E., Bivalacqua, T.J.: “Chronic Oral Administration of the Arginase Inhibitor 2 (S)-amino-6-boronohexanoic acid (ABH) Improves Erectile Function in Aged Rats.” J. Androl. 33 (2012), 1169-75.

  198. Facio Jr., F.N., Burnett, A.L.: “Protective Effect of Annexin-A1 against Irreversible Damage to Cavernous Tissue after Cavernous Nerve Injury in the Rat.” BJU Int. 110 (2012), 1346-51.

  199. Salonia, A., Burnett, A.L., Graefen, M., Hatzimouratidis, K., Montorsi, F., Mulhall, J.P., Stief, C.: ”Prevention and Management of Postprostatectomy Sexual Dysfunctions. Part 1: Choosing the Right Patient at the Right Time for the Right Surgery.” Eur Urol. 62 (2012) 261-72.

  200. Salonia, A., Burnett, A.L., Graefen, M., Hatzimouratidis, K., Montorsi, F., Mulhall, J.P., Stief, C.: ”Prevention and Management of Postprostatectomy Sexual Dysfunctions. Part 2: Recovery and Preservation of Erectile Function, Sexual Desire, and Orgasmic Function.” Eur Urol. 62 (2012) 273-86.

  201. Musicki, B., Liu, T., Sezen, S.F., Burnett, A.L.: “Targeting NADPH Oxidase Decreases Oxidative Stress in the Transgenic Sickle Cell Mouse Penis.” J. Sex Med. (2012) [Epub ahead of print].

  202. Morrison, B.F., Burnett, A.L.: “Stuttering Priapism: Insights into Pathogenesis and Management.” Curr Urol Rep. 13 (2012) 268-76.

  203. Rowland, D.L., Myers, A.L., Adamski, B.A., Burnett, A.L.: Role of Attribution in Affective Responses to a Partnered Sexual Situation among Sexually Dysfunctional Men.” BJU Int. 111(2013), E103-9.

  204. Wang, R. Burnett, A.L., Heller, W.H., Omori, K., Kotera, J., Kikkawa, K., Yee, S., Day, W.W., Didonato, K., Peterson, C.A.: “Selectivity of Avanafil, a PDE5 Inhibitor for the Treatment of Erectile Dysfunction: Implications for Clinical Safety and Improved Tolerability.” J. Sex Med. 9(2012) 2122-9.

  205. Nehra, A., Jackson, G., Minor, M., Billups, K.L., Burnett, A.L., Buvat, J., Carson, C.C., Cunningham, G.R., Ganz, P., Goldstein, I., Guay, A.T., Hackett, G., Kloner, R.A., Kostis, P., Ramsey, M., Rosen, R., Sadovsky, R., Seftel, A.D., Shabsigh, R., Vlachopoulos, C., Wu, F.C.: “The Princeton III Consensus Recommendations for the Management of Erectile Dysfunction and Cardiovascular Disease.” Mayo Clin Proc. 87 (2012), 766-78.

  206. Burnett, A.L., Hellstrom, W.J.: “Management of Erectile Dysfunction: Great Progress, Greater Promise.” J. Androl. 33(2012), 1107-10.

  207. Cellek, S., Bivalacqua, T.J., Burnett, A.L., Chitaley, K., Lin, C.S.: “Common Pitfalls in Some of the Experimental Studies in Erectile Function and Dysfunction: A Consensus Article.” J. Sex Med. 9 (2012), 2770-84.

  208. Lagoda, G., Sezen, S.F., Cabrini, M.R., Musicki, B., Burnett, A.L.: “Molecular Analysis of Erection Regulatory Factors in Sickle Cell Disease-Associated Priapism in Human Penis.” J. Urol. 189(2013), 762-8.

  209. Hurt, K.J., Sezen, S.F., Lagoda, G.F., Musicki, B., Rameau, G.A., Snyder, S.H., Burnett, A.L.: “Cyclic AMP-Dependent Phosphorylation of Neuronal Nitric Oxide Synthase Mediates Penile Erection.” Proc Natl Acad Sci USA. 109(2012), 16624-9.

  210. Segal, R.L., Readal, N., Pierorazio, P.M., Burnett, A.L., Bivalacqua, T.J.: “Corporal Burnett “Snake” Surgical Maneuver for the Treatment of Ischemic Priapism: Long-Term Follow-Up.” J. Urol. 189(2013), 1025-9.

  211. Hannan, J.L., Albersen, M., Kutlu, O., Gratzke, D., Stief, C.G., Burnett, A.L., Lysiak, J.J., Hedlund, P., Bivalacqua, T.J.: “Inhibition of Rho-kinase Improves Erectile Function, Increases Nitric Oxide Signaling and Decreases Penile Apoptosis in a Rat Model of Cavernous Nerve Injury.” J. Urol. 189(2013), 1155-61.

  212. Segal, R.L., Bivalacqua, T.J., Burnett, A.L.: “Irbesartan Promotes Erection Recovery After Nerve-Sparing Radical Retrobupic Prostatectomy: A Retrospective Long-Term Analysis.” BJU Int. 10 (2012), 1782-6.

  213. Levine, L.A., Burnett, A.L.: “Standard Operating Procedures for Peyronies‟s Disease.” J. Sex Med. 10 (2013), 230-44.

  214. Mulhall, J.P., Burnett, A.L., Wang, R., McVary, K.T., Moul , J.W., Bowden, C.H., Didonato, K., Shih, W., Day, W.W.: “A Phase 3, Placebo-Controlled Study of the Safety and Efficacy of Avanafil for the Treatment of Erectile Dysfunction Following Nerve-Sparing Radical Prostatectomy.” J. Urol. 189(2012), 2229-36.

  215. Massanyi, E.Z., Gupta, A., Goel, S., Gearhart, J.P., Burnett, A.L., Bivalacqua, T.J., Redett, R.J.: “Radial Forearm Free Flap Phalloplasty for Penile Inadequacy in Exstrophy Patients.” J. Urol. (2012) [Epub ahead of print].

  216. Olujohungbe, A., Burnett, A.L.: “How I Manage Priapism due to Sickle Cell Disease.” Br. J. Haematol. 160(2013), 754-65.

  217. Nehra, A., Jackson, G., Miner, M., Billups, K.L., Burnett, A.L., Buvat, J., Carson, C.C., Cunningham, G.R., Goldstein, I., Guay, A.T., Hackett, G., Kloner, R.A., Kostis, J., Montorsi, P., Ramsey, M., Rosen, R.C., Sadovsky, R., Seftel, A.,D., Vlachopoulos, C., Wu, F.C.: “Diagnosis and Treatment of Erectile Dysfunction for Reduction of Cardiovascular Risk.” J. Urol. 189(2013), 2031-8.

  218. Porst, H., Burnett, A.L., Brock, G., Ghanem, H., Giuliano, F., Glina, S., Hellstrom, W., Martin-Morales, A., Salonia, A., Sharlip, I., The ISSM Standards Committee for Sexual Medicine: “SOP Conservative (Medical and Mechanical) Treatment of Erectile Dysfunction.” J. Sex Med. 10(2013), 130-171.

  219. Burnett, A.L., Kan-Dobrosky, N., Miller, M.G.: “Testosterone Replacement with 1% Testosterone Gel and Priapism: No Definite Risk Relationship”. J. Sex Med. 10(2013), 1151-61.

  220. Chaux A., Cubilla A.L., Haffner M.C., Lecksell K.L., Sharma R., Burnett A.L., Netto G.J.: “Combining Routine Morphology, p16INK4a Immunohistochemistry, and in situ Hybridization for the Detection of Human Papillomavirus Infection in Penile Carcinomas: A Tissue Microarray Study Using Classifier Performance Analyses.” Urol Oncol. (2013) [Epub ahead of print].

  221. Chung J.Y., Chen H., Midzak A., Burnett A.L., Papadoulos V., Zirkin B.R.: “Drug Ligand-Induced Activation of Translocator Protein (TSPO) Stimulates Steroid Production by Aged Brown Norway Rat Leydig Cells.” Endocrinology. 154 (2013), 2156-65.

  222. Burnett A.L.: “Current Rehabilitation Strategy: Clinical Evidence for Erection Recovery After Radical Prostatectomy.” Transl Androl Urol. 2(2013), 24-31.

  223. Morrison B.F., Reid M., Madden W., Burnett A.L.: “Testosterone Replacement Therapy Does Not Promote Priapism in Hypogonadal Men with Sickle Cell Disease: 12-month Safety Report.” Andrology, (2013) [Epub ahead of print].

  224. Segal, R.L., Burnett A.L.: “Surgical Management for Peyronie‟s Disease.” World J. Mens Health. 31(2013), 1-11.

  225. Jackson, G., Nehra, A., Miner, M., Billups, K.L., Burnett, A.L., Buvat, J., Carson, C.C., Cunningham, G., Goldstein, I., Guay, A.T., Hackett, G., Kloner, R.A., Kostis, J.B., Montorsi, P., Ramsey, M., Rosen, R., Sadovsky, R., Seftel, A.D., Shabsigh, R., Vlachopoulos, C., Wu, F.C.: “The Assessment of Vascular Risk in Men with Erectile Dysfunction: The Role of the Cardiologist and General Physician.” Int J. Clin. Pract. (2013) [Epub ahead of print].

  226. Segal, R.L., Cabrini, M.R., Harris, E.D., Mostwin, J.L., Bivalacqua, T.J., Burnett, A.L.: “Combined Inflatable Penile Prosthesis-Artificial Urinary Sphincter Implantation: No Increased Risk of Adverse Events Compared to Single or Staged Device Implantation.” J. Urol. (2013) [Epub ahead of print].

  227. Bivalacqua, T.J., Musicki, B., Hsu, L.L., Berkowitz, D.E., Champion, H.C., Burnett, A.L.: “Sildenafil Citrate-Restored eNOS and PDE5 Regulation in Sickle Cell Mouse Penis Prevents Priapism Via Control of Oxidative/Nitrosative Stress.” PLoS One. (2013) [Epub ahead of print}.

  228. Chaux, A., Munari, E., Katz, B., Sharma, R., Lecksell, K., Cubilla, A.L., Burnett, A.L., Netto, G.J.: “The Epidermal Growth Factor Receptor is Frequently Overexpressed in Penile Squamous Cell Carcinomas: A Tissue Microarray and Digital Image Analysis Study of 112 Cases.” Hum. Pathol. (2013) [Epub ahead of print].

  229. Segal, R., Tajkarimi, K., Burnett, A.L.: “Viberect® Penile Vibratory Stimulation System: Evaluation of Its Erectogenic Efficacy.” Can. J. Urol. (2013) [Epub ahead of Print].

  230. Cabrini, M.R., Sezen, S.F., Lagoda, G., Segal, R.L., Feng, Z., Andreoni, C., Burnett, A.L.: “Fibrotic Protein Expression Profiles in Penile Tissue of Patients with Erectile Dysfunction.” Urology (2013) [Epub ahead of print].

Non-peer-reviewed scientific articles


  1. Burnett, A.L.: “Management of Chronic Orchialgia: Consider A Multidisciplinary Approach.” AUA News, Jan/Feb (1997).

  2. Burnett, A.L.: “Viagra and Women.” The Johns Hopkins Health Insider, 1 (1998), 1-2.

  3. Burnett, A.L.: “Impotence: All About the Revolution in Treatment and Prevention.” Bottom Line Health, 12 (1998), 13-4.

  4. Burnett, A.L.: “Significance of the Nitric Oxide Cascade in Erectile Function.” Drugs of Today, 36(2-3) (2000), 155-62.

  5. Burnett, A.L.: “Nitric Oxide Synthase and Heme Oxygenase Knockout Mice - What Have We Learned?” Int. J. Impotence Res., 12 (2000), S42-S44.

  6. Burnett, A.L.: “Innovations in Experimental Models in ED and FSD Research. Introduction.” Int. J. Impotence Res., 13 (2001), 134.

  7. Burnett, A.L.: “General Use of Animal Models for Investigation of the Physiology of Erection.” Int. J. Impotence Res., 13 (2001), 135-9.

  8. Burnett, A.L.: “Viagra in Men and Women.” Postgrad. Obstet. Gyn., 21(25), (2001), 1-6.

  9. Burnett, A.L.: “Smoking and Erectile Dysfunction.: hisandherhealth.com (2001).

  10. Montorsi, F., Burnett, A.L.: “Erectile Dysfunction after Radical Prostatectomy.” B.J.U.Int. 93 (2004), 1-2.

  11. Burnett, A.L.: “A Consumer‟s Guide to Impotence Drugs.” Johns Hopkins Med Lett Health After 50 17 (2004), 6.

  12. Burnett, A.L.: “From Bench to Bedside: Exciting New Research in Erectile Dysfunction.” AUA News, 9 (8), (2004).

  13. Burnett, A.L.: “Current Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction.” Epocrates Mobile CME ™, 127 (2005).

  14. Burnett, A.L.: “Erectile Function Outcomes in the Current Era of Anatomic Nerve-Sparing Radical Prostatectomy.” Reviews in Urology, 8 (2006), 47-53.

  15. Mulcahy, J.J., Burnett, A.L.: “Preserving the Infected Prosthetic Device.” AUA News, 15 (8), (2010), 2-4.

  16. Carson, C., Brock, G., Burnett, A., Darouiche, R., de Lissovoy, G., Mulcahy, J., Ralph, D.: “Global Perspectives on Inflatable Penile Prostheses Infection Prevention and Management.” Urology Times, September 2010.

  17. Tajkarimi, K., Burnett, A.L.: “The Role of Genital Afferent Nerve Stimulation for Erectile Dysfunction and Urinary Disorders.” AUA News, 19 (1), (2012), 1-4.

Editorials, Reviews


  1. Burnett, A.L.: “Commentary, re: 'Nerves from Pelvic Plexus Contribute to Chronic Orchidalgia‟ by Zorn, B.H. et al., Lancet 1994; 343:1161.” Pain Med. J. Club J., 1,1 (1995), 40-1.

  2. Burnett, A.L.: “Book Review, re: 'Gynecologic and Obstetric Urology' ed. by H.J. Buchsbaum and J.D. Schmidt.” J. Urol., 154 (1995), 1984-5.

  3. Burnett, A.L.: “Commentary, re:'Psychological Problems in Chronic Prostatitis Patients with Pain' by Egan, K.J. et al., Clin. J. Pain 1994; 10:218.” Pain Med. J. Club J., 1,4 (1995), 197-8.

  4. Burnett, A.L.: “Commentary, re: 'Phantom Orchalgia' by Holland, J.M. et al. ,J. Urol. 1994; 152:2291.” Pain Med. J. Club J., 1,4 (1995), 201-2.

  5. Burnett, A.L.: “Commentary, re: 'Topical Spinal Administration of a Nitric Oxide Synthase Inhibitor Prevents the Hyperreflexia Associated with a Rat Model of Persistent Visceral Pain' by Rice, A.S.C., Neurosci. Lett. 1995; 187:111.” Pain Med. J. Club J., 2,3 (1996), 151-2.

  6. Burnett, A.L.: “Review of Impotence Literature.” Int. J. Impotence Res., 9 (1997), 57-8.

  7. Burnett, A.L.: “Book Review, re: 'Female Urology' ed. by S. Raz.” J. Urol., 157 (1997), 2033-4.

  8. Burnett, A.L.: “Review of Impotence Literature.” Int. J. Impotence Res., 9 (1997), 109-10.

  9. Burnett, A.L.: “Commentary, re: 'Capsaicin in Treatment of Loin Pain/Hematuria Syndrome' by Bultitude, M.I., Lancet 1995; 345:921.” Pain Med. J. Club J., 3,1 (1997), 24-5.

  10. Burnett, A.L.: “Commentary, re: 'The Evaluation of Pelvic Injury in the Female Athlete' by Short, J.W., et al., Sports Med 1995; 20:422.” Pain Med. J. Club J., 3,2 (1997), 105-7.

  11. Burnett, A.L.: “Review of Impotence Literature.” Int. J. Impotence Res., 9 (1997), 173-4.

  12. Burnett, A.L.: “Commentary, re: 'Urinary Nitric Oxide Synthetase Activity and Cyclic GMP Levels are Decreased with Interstitial Cystitis and Increased with Urinary Tract Infections' by Smith, S.D., et al., J. Urol 1996; 155:1432.” Pain Med. J. Club J., 3,3 (1997), 153-5.

  13. Burnett, A.L.: “Review of Impotence Literature.” Int. J. Impotence Res., 10 (1998), 65-6.

  14. Burnett, A.L.: “Review of Impotence Literature.” Int. J. Impotence Res., 10 (1998), 103-4.

  15. Burnett, A.L.: “Review of Impotence Literature.” Int. J. Impotence Res., 10 (1998), 199-200.

  16. Burnett, A.L.: “Review of Impotence Literature.” Int. J. Impotence Res., 10 (1998), 265-6.

  17. Burnett, A.L.: “Review of Impotence Literature.” Int. J. Impotence Res., 11 (1999), 57-8.

  18. Burnett,A.L.: “Book Review, re: „ErectileDysfunction‟ ed. by A. Morales.” Urology (1999), 580.

  19. Burnett, A.L.: “Review of Impotence Literature.” Int. J. Impotence Res., 11(1999), 239-40.

  20. Burnett, A.L.: “Review of Impotence Literature.” Int. J. Impotence Res., 11(1999), 355-6.

  21. Burnett, A.L.: “Review of Impotence Literature.” Int. J. Impotence Res., 12 (2000), 245.

  22. Burnett, A.L.: “Review of Impotence Literature.” Int. J. Impotence Res., 12 (2000), 295-6.

  23. Burnett, AL.: “Review of Impotence Literature.” Int. J. Impotence Res., 12 (2000), 340-1.

  24. Burnett, A.L.: “Commentary, re: „Report of the International Consensus Development Conference on Female Sexual Dysfunction: Definitions and Classifications‟ by Basson R., et al, J. Urol 2000; 163: 888.” J. Sex Marit. Ther., 27 (2001), 121-2.

  25. Burnett, A.L.: “Book Review, re: „Men‟s Health‟ ed. by R.S.Kirby, M.G. Kirby and R.N. Farah.” Urology, 57 (2001), 209.

  26. Burnett, A.L.: “Review of Impotence Literature.” Int. J. Impotence Res., 13 (2001), 187-8.

  27. Burnett, A.L.: “Review of Impotence Literature.” Int. J. Impotence Res., 13 (2001), 360-2.

  28. Burnett, A.L.: “Book Review, re: „Male Sexual Function: A Guide to Clinical Management‟ ed. by
    J.J. Mulcahy.” Urology 59 (2002), 795.

  29. Burnett, A.L.: “Editorial Commentary, re: „Environmental agents and erectile dysfunction: a study in a consulting population‟ by Oliva A., et al,” J. Androl. 23 (2002), 479-80.

  30. Burnett, A.L.: “Review of Impotence Literature.” Int. J. Impotence Res., 14 (2002), 316.

  31. Burnett, A.L.: “Editorial Comment 2, re: „Efficacy of Tadalafil for the Treatment of Erectile
    Dysfunction at 24 and 36 Hours after Dosing: a Randomized Controlled Trial‟ by Porst H., et al,
    Urology, 62 (2003), 126.

  32. Nehra, A., Steers, W.D., Althof, S.E., Andersson, K.E., Burnett, A.L., Costabile, R.A., Goldstein, I.,
    Kloner, R.A., Lue, T.F., Morales, A., Rosen, R.C., Shabsigh, R., Siroky, M.B., King, L.: “Third International Conference on the Management of Erectile Dysfunction: Linking Pathophysiology and Therapeutic Response.” J. Urol., 170 (2003), S3-S5.

  33. Burnett, A.L.: “Book Review, re: „The Harvard Medical School Guide to Men‟s Health‟ by H.B.
    Simon.” Urology 62 (2003), 590.

  34. Burnett, A.L.: “Erectile Dysfunction.” In: Shah, J. (Ed.) Urology Highlights 2004-05. Health Press
    Limited: Oxford, UK, 2005.

  35. Burnett, A.L.: “Widening the Scope of Erectile Dysfunction Risk Associations.” J. Urol., 174 (2005), 12-3.

  36. Burnett, A.L.: “Invited Comments on Mulhall et al. The Use of an Erectogenic Pharmacotherapy Regimen Following Radical Prostatectomy Improves Recovery of Spontaneous Erectile Function.” J. Sex. Med., 2 (2005), 540.

  37. Burnett, A.L.: “Treatment Strategies for “Non-Responders‟” to Tadalafil and Vardenafil: A Real Life Study.” Eur. Urol., [Epub ahead of print].

  38. Burnett, A.L.: “Surgeon-Scientist: Another Perspective.” J. Androl., 27 (2006), 324-5.

  39. Burnett, A.L.: “Editorial Commentary, re: „Brain-Derived Neurotrophic Factor (BDNF) Acts Primarily via JAK/STAT Pathway to Promote Neurite Growth in the Major Pelvic Ganglion of the Rat: Part 1 and 2‟ by Bella A.J., et al, J. Sex Med., 3 (2006), 828-9.

  40. Burnett, A.L.: “Editorial Comment, re: „Pelvic Autonomic Nerve Mapping by Intraoperative Electrical Stimulation‟ by Takenaka A., et al, J. Urol., 177 (2007), 229.

  41. Burnett, A.L.: “Editorial Comment, re: „Penile Carcinoma: The Role of Koilocytosis in Groin Metastasis and the Association with Disease Specific Survival‟ by de Paula, A.A.P., et al,” J. Urol., 177 (2007), 1343.

  42. Burnett, A.L.: “Editorial Comment, re: „Impact of Unilateral Sural Nerve Graft on Recovery of Potency and Continence Following Radical Prostatectomy: 3-Year Longitudinal Study‟ by Namiki, S. et al,” J. Urol., 178 (2007), 216.

  43. Burnett, A.L.: “Editorial Comment, re: ‘Congenital Penile Curvature: Dermal Grafting Procedure to Prevent Penile Shortening in Adults‟ by Simonato, A., et al,” Eur. Urol. 51 (2007), 1428.

  44. Burnett, A.L.: “Editorial Comment, re: „Does Androgen Suppression Plus Radiation Therapy Lead to Changes in Penile Length in Prostate Cancer Patients?‟ by Haliloglu, A. et al,” Nature Clin. Pract. Urol. 4 (2007), 530-1.

  45. Burnett, A.L.: “Against: No Surgery for Stuttering Priapism.” J. Urol. 181 (2009), 450-1.

  46. Burnett, A.L.: “2008 American Urological Association Foundation Summer Research Conference on
    Sexual Medicine.” J. Sex. Med. 6 Suppl 3 (2009), 201-2.

  47. Burnett, A.L.: “Editorial Preface to the Review Articles from the 2008 ASA Satellite Symposium “Therapeutic Strategies for Male Sexual and Hormonal Health.” J. Androl. 30 (2009), 351.

  48. Cheskin, L.J., Burnett, A.L.: “A Behavioural Weight-Loss Programme was Better Than an Education Programme for Urinary Incontinence in Overweight and Obese Women.” Evid. Based Med. 74 (2009), 118.

  49. Burnett, A.L.: “Editorial Comment, re: „Extrafascial versus Interfascial Nerve-Sparing Technique for Robotic-Assisted Laparoscopic Prostatectomy: Comparison of Functional Outcomes and Positive Surgical Margins Characteristics.‟ by S. Shikanov, et al,” Urology 74 (2009), 617.

  50. Burnett, A.L.: “Castration for Treating Recurrent Priapism: Can We Do Better?” J. Androl. (2011) [Epub ahead of print].

  51. Burnett, A.L., Segal, R.: “Beyond the Abstract „Erectile Preservation following Radical Prostatectomy‟ by R. Segal, A.L. Burnett,” UroToday.com, 4 January 2012.

  52. Burnett, A.L., Perreault, S.D., Sandlow, J.: “Commemorating the Journal of Andrology‟s Distinguished History.” J. Androl. 33(2012), 1067.

  53. Burnett, A.L., Perreault, S.D., Sandlow, J., Bartke, A., Orgebin-Crist, M.C., Desjardins, C., Lewis R.W., Tindall, D., Hamilton, D.W., Pryor, J.L., Schlegel, P.N., Hardy M.P.: “Parting Messages from Current and Former Editors of the Journal of Andrology.” J. Androl. 33(2012), 1068-74.


Books


  1. Burnett, A.L. Patients‟ Guide to Prostate Cancer: Johns Hopkins Medicine. Jones and Barlett Publishers: Sudbury, MA, 2010

  2. Burnett, A.L. II, Morris, N.S. Prostate Cancer Survivors Speak Their Minds: Advice on Options, Treatments, and Aftereffects. John Wiley & Son, Inc.: Hoboken, NJ, 2010

Book Chapters


  1. Berrettini, W.H., Bardakjian, J., Burnett, A.L., Nurnberger,J.I., Gershon,E.S.: “Beta- Adrenergic Receptor Function in Human Adult Skin Fibroblasts: A Study of Manic- Depressive Illness.” In: Clark, S., (Ed.) Receptors, Antidepressants, and Depression. Ciba Foundation, Symposium No. 123, 1986.

  2. Mostwin, J.L., Burnett, A.L.: “Anatomic Aspects of Urinary Incontinence.” In: O'Donnell, P.D., (Ed.) Urinary Incontinence. Mosby-Year Book, Inc: St. Louis, MO, 1996.

  3. Burnett, A.L.: “Neurophysiology of Erectile Function and Dysfunction.” In: Hellstrom, W., (Ed.) Handbook of Sexual Dysfunction. Allen Press, Inc.: Lawrence, KS, 1999.

  4. Wesselmann, U., Burnett, A.L.: “Genitourinary Pain.” In: Wall, P.D., Melzack, R. (Eds.) Textbook of Pain. 4th Edition. Churchill Livingstone: New York, NY, 1999.

  5. Burnett, A.L.: “Significance of the Nitric Oxide Cascade in Erectile Function.” In: Melman, A. (Ed.) Treatment of Erectile Dysfunction: Clinical and Research Perspectives. Telesymposia Proceedings, Prous Science: Barcelona, Spain, 2000.

  6. Andersson, K.-E, Burnett, A.L., Chen, K.K., Christ, G. J., Rampin, O., Stief, C.: “ Current Research and Future Therapies.” In: Jardin, A., Wagner, G., Khoury, F., Giuliano, F., Padma-Nathan, H., Rosen, R. (Eds.) Erectile Dysfunction. Health Publication Ltd: Plymouth, United Kingdom, 2000.

  7. Burnett, A.L., Rodriguez, R., Jarrett, T.: “Male Anatomy and Physiology.” In: Greenfield, L.J., Mulholland, M.W., Oldham, K.T., Zelenock, G.B., Lillemoe, K.D. (Eds.) Surgery: Scientific Principles and Practice, 3rd Edition. Lippincott-Raven Publishers: Philadelphia, PA, 2001.

  8. Burnett, A.L.: “Erectile Dysfunction Module.” In: Goldman D.R., (Ed.) Physicians‟ Information and Education Resources (PIER). American College of Physicians - American Society of Internal Medicine: Philadelphia, PA, 2001.

  9. Burnett, A.L.: “Physiology of Erection and Pathophysiology of Erectile Dysfunction.” In: Robaire, B., Chemes, H., Morales, C.R. (Eds.) Andrology in the 21st Century. Medimond Publishing Company, Inc.: Englewood, N.J., 2001.

  10. Burnett, A.L.: “New Advances in the Medical Management of Sexual Dysfunction.” In: Robaire, B., Chemes, H., Morales, C.R. (Eds.) Andrology in the 21st Century. Medimond Publishing Company, Inc.: Englewood, N.J., 2001.

  11. Burnett, A.L.: “Smoking and Erectile Dysfunction.” In: Samet, J. (Ed.) Active Smoking and Health: A Report of the Surgeon General. U.S. Department of Health and Human Services: Rockville, MD, 2004.

  12. Fagan, P.J., Burnett, A.L. Rogers, L., Schmidt, W.W. Jr.: “Sexual Disorders.” In: Barker, L.R., Burton, J.R., Zieve, P.D., Fiebach, N., Kern, D.E., Thomas, P., Ziegelstein, R. (Eds.) Principles of Ambulatory Medicine, Sixth Edition. Lippincott, Williams, and Wilkins: Philadelphia, PA, 2001.

  13. Burnett, A.L., Chang, A.G., Sezen, S.F., Crone, J.K.: “Cholinergic Stimulation of Penile Erection in
    Mice.” In: Robaire, B., Chemes, H., Morales, C.R. (Eds.) Andrology in the 21st Century. Medimond Publishing Company, Inc.: Englewood, N.J., 2001.

  14. Burnett, A.L.: “Epidemiology and Physiology of Erectile Dysfunction.” In: Carson, C. C., Nehra, A.
    (Eds.) PDE-5 Inhibitors in the Treatment of Erectile Dysfunction. InforMEDical Communications,
    Inc.: Carlisle, MA, 2001.

  15. Wesselmann, U., Burnett, A.L.: “Genitourinary Pain.” In: Melzack, R., Wall, P.D. (Eds.) Handbook
    of Pain Management. Churchill Livingstone: Edinburgh, Scotland, 2002.

  16. Burnett, A.L.: “Special Populations.” In: Nehra, A. (Ed.) Treating Erectile Dysfunction: Advances
    in PDE-5 Inhibitors. InforMedical Communications, Inc.: Carlisle, MA, 2002.

  17. Burnett, A.L.: “Urinary Incontinence: Management Strategies and the Impact of Emerging
    Therapies.” In: Burnett, A.L. (Ed.) Clinical and Cost-Effective Strategies in the Management of Urinary Incontinence. Managed Care Consultant, Vol. 2, No. 7, 2002.

  18. Burnett, A.L.: “Penile Anatomy.” In: Teloken, C., Tannhauser, M., Teodosio Da Ros, C. (Eds.)
    Sexual Dysfunction. Livraria e Editora Revinter Ltda: Matriz, Brasil, 2003.

  19. Burnett, A.L.: “Pathophysiology of Erectile Dysfunction.”In: Teloken, C., Tannhauser, M.,Teodosio Da Ros, C. (Eds.) Sexual Dysfunction. Livraria e Editora Revinter Ltda: Matriz, Brasil, 2003.

  20. Anderson, K.E., Argiolas, A., Burnett, A.L., Chen, K.K., Mills, T.M., Steers, W.D.: “Future Treatment Targets.” In: Lue, T.F., Basson, R., Rosen, R., Giuliano, F., Khoury, S., Montorsi, F. (Eds.) Sexual Medicine: Sexual Dysfunctions in Men and Women. Health Publications Ltd: Plymouth, United Kingdom, 2004.

  21. Burnett, A.L.: “Urinary and Sexual Dysfunction in Multiple Sclerosis and Myelitis.” In: Johnson, R.T.et al (Eds.) Current Therapy in Neurologic Disease. Elsevier Inc.: Philadelphia, PA, 2005.

  22. Chan, D.Y., Burnett, A.L., Rodriguez, R., Jarrett, T.W.: “Male Genitourinary Anatomy andPhysiology.” In: Mulholland, M.W., Lillemoe, K.D., Doherty, G.M., Maier, R.V., Upchurch, G.R. Jr. (Eds.) Greenfield‟s Surgery: Scientific Principles and Practice, 4th Edition. Lippincott Williams &Wilkins: Philadelphia, PA, 2006.

  23. Derogatis, L.R., Burnett, A.L., Rogers, L.C., Schmidt, Jr. C.W., Fagan, P.J.: “Sexual Disorders: Diagnosis and Treatment.” In: Fiebach, N.H., Kern, D.E., Thomas, P.A., Ziegelstein, R.C. (Eds.) Baker, Burton and Zieve‟s Principles of Ambulatory Medicine, 7th Edition. Lippincott Williams &Wilkins: Philadelphia, PA, 2007.

  24. Roehrborn, C.G., Uzzo, R.G., Burnett, A.L., Dougherty, J., Lavelle, J.P., Lofholm, P., Miner, M.M., Quallich, S.: “Benign Prostatic Hyperplasia: Applying the Guidelines to Clinical Practice.” Supplement to The Clinical Advisor, Haymarket Media Inc.: Montvale, NJ, 2006.

  25. Burnett, A.L.: “Erectile Dysfunction: Science and Medicine.” In: Rowland, D.L. (Ed.) Annual Review of Sex Research, Volume XVII. Stoyles Graphic Services, Mason City, IA, 2006.

  26. Burnett, A.L.: “Priapism.” In: Wein, A.J., Kavoussi, L.R., Novick, A.C., Partin, A.W., Peters, C.A. (Eds.): Campbell-Walsh UROLOGY, 9th Edition. Saunders Elsevier: Philadelphia, PA , 2007.

  27. Burnett, A.: “Treatment Strategies for Erectile Dysfunction.” In: Feneley, M., Payne, H. (Eds.) Therapeutic Strategies in Prostate Cancer. Clinical Publishing: Oxford, UK, 2007.

  28. Burnett, A.L.: “Nerve Regeneration: Grafts, Conduits, and Strategies.” In: Montague, D.K., Angermeier, K.W., Gill, I.S., Ross, J.H. (Eds.) Textbook of Reconstructive Urologic Surgery. Informa Healthcare: London, UK 2007.

  29. Canguven, O., Burnett, A.L.: “Future of Therapy of Priapism.” In: Abdel-Hamid, I.A. (Ed.) Advances in Sexual Medicine: Drug Discovery Issues. Research Signpost: Kerala, India, 2008.

  30. Burnett, A.L. II: “Neuromodulatory Drugs for the Radical Prostatectomy Patient.” In: Mulhall, J.P. (Ed.) Sexual Function in the Prostate Cancer Patient, Current Clinical Urology Series. Humana Press, New York, NY, 2009.

  31. Musicki, B., Burnett, A.L. II: “Pathophysiology of Erectile Dysfunction: Molecular Basis.” In: Carson, C.C. III, Kirby, R.S., Goldstein, I., Wyllie, M.G. (Eds.) Textbook of Erectile Dysfunction. Informa Healthcare: New York, NY, 2009.

  32. Burnett, A.L. II: “Environmental Erectile Dysfunction.” In: Carson, C.C. III, Kirby, R.S., Goldstein, I., Wyllie, M.G. (Eds.) Textbook of Erectile Dysfunction. Informa Healthcare: New York, NY, 2009.

  33. Bivalacqua, T.J., Strong, T.D., Champion, H.C., Burnett, A.L. II: “Stem and Endothelial Progenitor Cells in Erectile Biology: Future Therapeutic Applications and Potential Biomarker for Erectile Dysfunction.” In: Carson, C.C. III, Kirby, R.S., Goldstein, I., Wyllie, M.G. (Eds.) Textbook of Erectile Dysfunction. Informa Healthcare: New York, NY, 2009.

  34. Bivalacqua, T.J., Musicki, B., Champion, H.C., Burnett, A.L. II: “Phosphodiesterase Type 5 Inhibitor Therapy for Priapism.” In: Carson, C.C. III, Kirby, R.S., Goldstein, I., Wyllie, M.G. (Eds.) Textbook of Erectile Dysfunction. Informa Healthcare: New York, NY, 2009.

  35. Canguven, O., Burnett, A.L.: “Priapism Monograph.” British Medical Journal Publishing Group Ltd: London, 2009 (URL: https://online.epocrates.com).

  36. Bivalacqua, T.J., Burnett, A.L.: “Priapism.” In: Graham, S., Keane, T. (Eds.) Glenn‟s Urologic Surgery 7e. Lippincott, Williams & Williams, Philadelphia, PA, 2009.

  37. Pierorazio, P.M., Burnett, A.L.: “How Do Erections Occur? How Common is Erectile Dysfunction, What is its Etiology, and How Do You Evaluate Men with this Problem?” In: Robaire, B., Chan, P. (Eds.) Handbook of Andrology. Allen Press, Inc.: Lawrence, KS, 2010.

  38. Boyle, K.E., Burnett, A.L.: “Sexual Function and Dysfunction in Men and Women.” In: Legato, M.J. (Ed.) Principles of Gender-Specific Medicine. Academic Press/Elsevier: London, UK, 2010.

  39. Morrison, B.F., Burnett, A.L.: “Priapism: Medical and Surgical Therapy.” In: McVary, K.T. (Ed.) Contemporary Treatment of Erectile Dysfunction. Springer Science: New York, NY, 2011.

  40. Bivalacqua, T.J., Levey, H.R., Burnett, A.L.: “Priapism.” In: Mulhall, J.P. et al (Eds.) Cancer and Sexual Health, Current Clinical Urology. Springer Science: New York, NY, 2011.

  41. Burnett, A.L.: “Evaluation and Management of Erectile Dysfunction.” In: Wein, A.J., Kavoussi, L.R., Novick, A.C., Partin, A.W., Peters, C.A. (Eds.) Campbell-Walsh Urology, 10th Edition. Sanders Elsevier: Philadelphia, PA, 2011.

  42. Musicki, B., Burnett, A.L.: “Role of Oxidative Stress in ED: Unraveling the Molecular Mechanism.” In: Agarwal, A. et al (Eds.) Studies on Men‟s Health and Fertility, Oxidative Stress in Applied Basic Research and Clinical Practice. Springer Science: New York, NY, 2012.

  43. Bivalacqua, T.J., Burnett, A.L.: “Operations for Priapism.” In: Smith, J.A. Jr., Howards, S.S., Preminger, G.M. (Eds.) Hinman‟s Atlas of Urologic Surgery. Elsevier Saunders: Philadelphia, PA, 2012.

  44. Rosenblum, J.L., Burnett, A.L.: “Microsurgical Penile Revascularization, Replantation, and Reconstruction.” In: Sandlow J.I. (Ed.) Microsurgery for Fertility Specialists: A Practical Text. Springer Science: New York, NY, 2013.

  45. Morrison, B.F., Burnett, A.L.: “Urological Complications of Sickle Cell Disease (Lesson 29).” In: Carroll, P.R. et al (Eds.) AUA Update Series. AUA Education and Research, Inc.: Linthicum, MD 2012.

Books (Editorships)


  1. Gomella, L.G. (Ed-In-Chief); Andriole, G.L., Burnett, A.L., Casale, A.J., Flanigan, R.C., Keane, T.E., Moul, J.W., Thomas, R. (Assoc. Eds.) The 5-Minute Urology Consult, Second Edition. Wolters Kluwer Health/Lippincott, Williams and Wilkins: Philadelphia, PA, 2010 26

Other Media (audiovisual presentation)


  1. Walsh, P.C., Burnett, A.L., Partin, A.W.: “Anatomical Radical Retropubic Prostatectomy: Evolution of the Surgical Technique.” American Urological Association National Meeting. San Antonio, TX. May 15-20, 1993.



© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.| Disclaimer
Email: webmaster@urology.jhu.edu | 600 North Wolfe Street, Baltimore, Maryland 21287